These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 20486769)
1. Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy. Rimessi P; Fabris M; Bovolenta M; Bassi E; Falzarano S; Gualandi F; Rapezzi C; Coccolo F; Perrone D; Medici A; Ferlini A Hum Gene Ther; 2010 Sep; 21(9):1137-46. PubMed ID: 20486769 [TBL] [Abstract][Full Text] [Related]
2. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression. Lee JJA; Saito T; Duddy W; Takeda S; Yokota T Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539 [TBL] [Abstract][Full Text] [Related]
3. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient. Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540 [TBL] [Abstract][Full Text] [Related]
4. Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: in vitro mimicking and antisense modulation of the splicing abnormality. Gualandi F; Rimessi P; Cardazzo B; Toffolatti L; Dunckley MG; Calzolari E; Patarnello T; Muntoni F; Ferlini A Gene; 2003 Jun; 311():25-33. PubMed ID: 12853135 [TBL] [Abstract][Full Text] [Related]
5. A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy. Dwianingsih EK; Malueka RG; Nishida A; Itoh K; Lee T; Yagi M; Iijima K; Takeshima Y; Matsuo M J Hum Genet; 2014 Aug; 59(8):423-9. PubMed ID: 24871807 [TBL] [Abstract][Full Text] [Related]
6. Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene. Tran VK; Takeshima Y; Zhang Z; Yagi M; Nishiyama A; Habara Y; Matsuo M J Med Genet; 2006 Dec; 43(12):924-30. PubMed ID: 16738009 [TBL] [Abstract][Full Text] [Related]
7. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements. Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336 [TBL] [Abstract][Full Text] [Related]
8. Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markers. Malueka RG; Takaoka Y; Yagi M; Awano H; Lee T; Dwianingsih EK; Nishida A; Takeshima Y; Matsuo M BMC Genet; 2012 Mar; 13():23. PubMed ID: 22462762 [TBL] [Abstract][Full Text] [Related]
9. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene. Errington SJ; Mann CJ; Fletcher S; Wilton SD J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides. Aartsma-Rus A; Janson AA; Heemskerk JA; De Winter CL; Van Ommen GJ; Van Deutekom JC Ann N Y Acad Sci; 2006 Oct; 1082():74-6. PubMed ID: 17145928 [TBL] [Abstract][Full Text] [Related]
11. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272 [TBL] [Abstract][Full Text] [Related]
12. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]
14. In vivo study of an aberrant dystrophin exon inclusion in X-linked dilated cardiomyopathy. Cohen N; Rimessi P; Gualandi F; Ferlini A; Muntoni F Biochem Biophys Res Commun; 2004 May; 317(4):1215-20. PubMed ID: 15094399 [TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing system. Malueka RG; Yagi M; Awano H; Lee T; Dwianingsih EK; Nishida A; Takeshima Y; Matsuo M Nucleic Acid Ther; 2011 Oct; 21(5):347-53. PubMed ID: 21967521 [TBL] [Abstract][Full Text] [Related]
17. Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Mann CJ; Honeyman K; Cheng AJ; Ly T; Lloyd F; Fletcher S; Morgan JE; Partridge TA; Wilton SD Proc Natl Acad Sci U S A; 2001 Jan; 98(1):42-7. PubMed ID: 11120883 [TBL] [Abstract][Full Text] [Related]
18. Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient. Saito T; Nakamura A; Aoki Y; Yokota T; Okada T; Osawa M; Takeda S PLoS One; 2010 Aug; 5(8):e12239. PubMed ID: 20805873 [TBL] [Abstract][Full Text] [Related]
19. Efficient exon skipping by base-editor-mediated abrogation of exonic splicing enhancers. Qiu H; Li G; Yuan J; Yang D; Ma Y; Wang F; Dai Y; Chang X Cell Rep; 2023 Nov; 42(11):113340. PubMed ID: 37906593 [TBL] [Abstract][Full Text] [Related]
20. Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene. Greer K; Johnsen R; Nevo Y; Fellig Y; Fletcher S; Wilton SD Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]